Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nalbuphine vs Remifentanil on Respiratory Center
NCT04372342Phase 4Unknown
- Start
- May 2019
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nalbuphine in postoperative pain (2 arms). Primary endpoint: Richmond Agitation-Sedation Scale at 1 week. Status: unknown.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04372342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372342.